drugset / Trial / NCT00263185

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

NCT00263185

RandomizedFactorialTriple-blindSupportive care

Summary

The purpose of this study is to determine whether Vitamin D supplementation reduces the symptoms of muscle stiffness and joint tenderness that some patients may develop after starting therapy with Anastrozole for breast cancer.

Timeline

Start
2005-11
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Vitamin D Other / unclassified 400 iu
Subject Vitamin D Other / unclassified 50000 iu

Indications